Answers are grounded in this paper and cite their sources.
The coronavirus disease (COVID-19) caused by SARS-CoV-2 has raised significant public health concerns, leading to varying degrees of respiratory illness. Vitamins A, D, B6, B9, and B12 are essential for immune responses to viral infections, including COVID-19, while homocysteine, regulated by B vitamins, may affect inflammatory reactions and vascular complications. This study aimed to assess the levels of these micronutrients and homocysteine in children with COVID-19, exploring potential links to disease severity. Materials and Methods: The study, included 112 children with COVID-19 and 23 healthy controls. Serum levels of vitamins A, D, B6, B9, B12, and homocysteine were measured using the enzyme-linked immunosorbent assay. Results showed that children with mild COVID-19 had higher vitamin A levels (456.10 ng/ml) than those with moderate (347.30 ng/ml) and severe cases (242.90 ng/ml) (p < 0.05). Vitamin D and B6 levels also decreased with increased severity, from 30.91 ng/ml and 56.80 ng/ml in mild cases to 22.42 ng/ml and 39.41 ng/ml in severe cases, respectively (p < 0.05). Vitamin B9 was lower in severe cases (3.90 ng/ml) compared to mild (4.78 ng/ml) (p < 0.05), while B12 showed no significant differences. Conclusions: vitamins D, B6, and B9 appear to play a significant role in reducing COVID-19 severity in children, while vitamin A has a smaller effect, and B12 shows no notable influence. These findings suggest the importance of maintaining adequate vitamin levels during the COVID-19 pandemic to potentially mitigate disease severity.
No takes yet. Share an insight, caveat, or question.
Pavlyshyn et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: